Human SOST/Sclerostin Antibody Summary
Gln24-Tyr213
Accession # Q9BQB4
Applications
Human SOST Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of SOST/Sclerostin by Western Blot Response of serum sclerostin and Wnt/ beta ‐catenin signaling within scWAT to 4 weeks of SIT. (a) Serum sclerostin response to SIT. (b) Representative immunoblots of sclerostin, phosphorylated and total GSK3 beta, beta ‐catenin, and total protein loading control (Ponceau S) at pre‐SIT (labeled “a”) and post‐SIT (labeled “b”) with estimated molecular weights on the right. These representative samples are the same two participants (“1” and “2”) in sequence across proteins that highlight their response from pre‐ to post‐SIT. scWAT (c) sclerostin content, (d) total and phosphorylated GSK3 beta, and (e) total beta ‐catenin response to SIT relative to pre‐SIT. Bar charts have black lines that represent individual responses to SIT with group means presented as white (pre‐SIT) and gray (post‐SIT) bars ± SD. Paired t‐tests were used to examine changes pre‐ to post‐SIT Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35312183), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of SOST/Sclerostin by Western Blot Response of eWAT sclerostin content (A), serine9 phosphorylation status (B,D) both total GSK3b content (C), and total b-catenin content (E) to HFD and acute exercise, as well as representative immunoblots (F). Light grey bars represent sedentary mice and dark grey bars represent mice sampled 2 h following 2 h of acute endurance exercise and are grouped by diet; LFD = low fat diet; HFD = high fat diet. Proteins are corrected for by the house keeping protein vinculin and are all relative to LFD sedentary mice, data are presented as means ± SD and main effects are presented on graphs only if they are either close to or are significant. A two-way factorial ANOVA was used to examine main effects for diet and exercise as well their interaction. Tukey correction was used for multiple pairwise comparisons. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36685192), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of SOST/Sclerostin by Western Blot Response of eWAT sclerostin content (A), serine9 phosphorylation status (B,D) both total GSK3b content (C), and total b-catenin content (E) to HFD and acute exercise, as well as representative immunoblots (F). Light grey bars represent sedentary mice and dark grey bars represent mice sampled 2 h following 2 h of acute endurance exercise and are grouped by diet; LFD = low fat diet; HFD = high fat diet. Proteins are corrected for by the house keeping protein vinculin and are all relative to LFD sedentary mice, data are presented as means ± SD and main effects are presented on graphs only if they are either close to or are significant. A two-way factorial ANOVA was used to examine main effects for diet and exercise as well their interaction. Tukey correction was used for multiple pairwise comparisons. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36685192), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of SOST/Sclerostin by Western Blot Response of iWAT sclerostin content (A), serine9 phosphorylation status (B,D) both total GSK3b content (C), and total b-catenin content (E) to HFD and acute exercise, as well as representative immunoblots (F). Light grey bars represent sedentary mice and dark grey bars represent mice sampled 2 h following 2 h of acute endurance exercise and are grouped by diet; LFD = low fat diet; HFD = high fat diet. Proteins are corrected for by the house keeping protein vinculin and are all relative to LFD sedentary mice, data are presented as means ± SD and main effects are presented on graphs only if they are either close to or are significant. A two-way factorial ANOVA was used to examine main effects for diet and exercise as well their interaction. Tukey correction was used for multiple pairwise comparisons. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36685192), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of SOST/Sclerostin by Western Blot Response of iWAT sclerostin content (A), serine9 phosphorylation status (B,D) both total GSK3b content (C), and total b-catenin content (E) to HFD and acute exercise, as well as representative immunoblots (F). Light grey bars represent sedentary mice and dark grey bars represent mice sampled 2 h following 2 h of acute endurance exercise and are grouped by diet; LFD = low fat diet; HFD = high fat diet. Proteins are corrected for by the house keeping protein vinculin and are all relative to LFD sedentary mice, data are presented as means ± SD and main effects are presented on graphs only if they are either close to or are significant. A two-way factorial ANOVA was used to examine main effects for diet and exercise as well their interaction. Tukey correction was used for multiple pairwise comparisons. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36685192), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: SOST/Sclerostin
SOST, also known as sclerostin, belongs to the Cerberus/DAN family of secreted glycoproteins. SOST binds BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity and functions in bone homeostasis as a BMP antagonist.
Product Datasheets
Citations for Human SOST/Sclerostin Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
14
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Efficacy of Nerve-Derived Hydrogels to Promote Axon Regeneration Is Influenced by the Method of Tissue Decellularization
Authors: VK Kuna, A Lundgren, LO Anerillas, P Kelk, M Brohlin, M Wiberg, PJ Kingham, LN Novikova, G Andersson, LN Novikov
International Journal of Molecular Sciences, 2022-08-06;23(15):.
-
Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4-weeks of sprint interval training in young men with obesity
Authors: N Kurgan, H Islam, JBL Matusiak, BJ Baranowski, J Stoikos, VA Fajardo, REK MacPherson, BJ Gurd, P Klentrou
Physiological Reports, 2022-03-01;10(6):e15232.
-
Characterization of sclerostin's response within white adipose tissue to an obesogenic diet at rest and in response to acute exercise in male mice
Authors: N Kurgan, B Baranowski, J Stoikos, AJ MacNeil, VA Fajardo, REK MacPherson, P Klentrou
Frontiers in Physiology, 2023-01-04;13(0):1061715.
Species: Mouse
Sample Types: Protein
Applications: Western Blot -
Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
Authors: Qiushi Wei, Bin Wang, Hailan Hu, Chuhai Xie, Long Ling, Jianliang Gao et al.
International Journal of Molecular Medicine
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Western Blot, Immunocytochemistry -
Human osteocyte expression of Nerve Growth Factor: The effect of Pentosan Polysulphate Sodium (PPS) and implications for pain associated with knee osteoarthritis
Authors: CJM Stapledon, H Tsangari, LB Solomon, DG Campbell, P Hurtado, R Krishnan, GJ Atkins
PLoS ONE, 2019-09-26;14(9):e0222602.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Sclerostin expression in bone tumours and tumour-like lesions
Authors: Yusuke Inagaki, Edward S Hookway, Takeshi G Kashima, Mitsuru Munemoto, Yasuhito Tanaka, Andrew Bassim Hassan et al.
Histopathology
-
Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation.
Authors: Pereira R, Valta H, Tumber N, Salusky I, Jalanko H, Makitie O, Wesseling Perry K
PLoS ONE, 2015-09-21;10(9):e0138156.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Role of Wnt/ beta -catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients
Authors: Agnetha Folestad, Martin Ålund, Susanne Asteberg, Jesper Fowelin, Ylva Aurell, Jan Göthlin et al.
Acta Orthopaedica
-
Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
Authors: Pereira R, Juppner H, Gales B, Salusky I, Wesseling-Perry K
PLoS ONE, 2015-03-16;10(3):e0120856.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Sclerostin and Dickkopf-1 in Renal Osteodystrophy
Authors: Daniel Cejka, Johann Herberth, Adam J. Branscum, David W. Fardo, Marie-Claude Monier-Faugere, Danielle Diarra et al.
Clinical Journal of the American Society of Nephrology
-
Regulation of circulating sclerostin levels by sex steroids in women and in men.
Authors: Modder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S
J. Bone Miner. Res., 2011-01-01;26(1):27-34.
Species: Human
Sample Types: Serum
Applications: ELISA Development -
Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
Authors: Jilka RL, O'Brien CA, Bartell SM, Weinstein RS, Manolagas SC
J. Bone Miner. Res., 2010-11-01;25(11):2427-37.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Western Blot -
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
Authors: Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G
Arthritis Rheum., 2009-11-01;60(11):3257-62.
Species: Human
Sample Types: Serum
Applications: ELISA Development -
Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro.
Authors: Jager A, Gotz W, Lossdorfer S, Rath-Deschner B
J. Periodont. Res., 2009-09-23;45(2):246-54.
Species: Human
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC-P, Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human SOST/Sclerostin Antibody
There are currently no reviews for this product. Be the first to review Human SOST/Sclerostin Antibody and earn rewards!
Have you used Human SOST/Sclerostin Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
